Suppr超能文献

腹主动脉瘤的血管内治疗。

Endovascular treatment of hypogastric artery aneurysms.

机构信息

Department of Vascular and Endovascular Surgery, Wilhelminenhospital, Vienna, Austria.

Department of Vascular and Endovascular Surgery, Wilhelminenhospital, Vienna, Austria; Sigmund Freud Private University, Medical School, Vienna, Austria.

出版信息

J Vasc Surg. 2019 Oct;70(4):1107-1114. doi: 10.1016/j.jvs.2018.12.048. Epub 2019 May 27.

Abstract

OBJECTIVE

Internal iliac artery aneurysm (IIAA) is a rare entity. Its treatment can be technically challenging. The aim of this study was to evaluate the treatment possibilities in an era of advanced endovascular techniques and their potential to preserve iliac blood flow while reliably excluding the aneurysm.

METHODS

A retrospective analysis of 46 consecutive patients with endovascularly treated IIAA was performed. Data were collected from a single-institution aortoiliac database. The following end points were recorded: technique of aneurysm exclusion, technical success rates, perioperative morbidity and mortality, primary patency, and midterm follow-up.

RESULTS

Between September 2009 and May 2016, a total of 46 patients with 55 IIAAs were identified. The majority of patients (n = 39 [84.8%]) had aortoiliac aneurysms and seven had isolated IIAAs (15.2%). The following surgical techniques were used: implantation of iliac branch devices (IBDs; n = 29), occlusion of the internal iliac artery (IIA) by ostium coverage with or without prior coil embolization (n = 23), and other endovascular techniques (n = 3). Primary assisted technical success was achieved in 93.1% of IBD implantations and in 100% of occlusions by ostium coverage and other techniques. Overall 30-day mortality was 4.3% (n = 2) and 0% in electively treated patients. Assisted midterm patency after IBD implantation was 93.1%. Gluteal claudication occurred in seven patients (15.2%) who had undergone intentional or accidental occlusion of the IIA or the superior gluteal artery. Reintervention rates within the midterm follow-up were 13.8% (n = 4) after IBD implantation and 4.3% (n = 1) after coverage of the IIA ostium. No ruptures were observed during follow-up, and no complications occurred during reinterventions.

CONCLUSIONS

Implantation of IBD devices for the treatment of hypogastric artery aneurysms shows good technical results with a high primary patency and a low rate of perioperative complications. Although successful aneurysm exclusion while preserving pelvic blood flow is associated with a higher rate of reinterventions during midterm follow-up, it should be taken into consideration, especially in complex endovascular aortoiliac aneurysm repair.

摘要

目的

髂内动脉动脉瘤(IIAA)是一种罕见的疾病。其治疗在技术上具有挑战性。本研究的目的是评估在先进的腔内技术时代的治疗可能性,以及在可靠地排除动脉瘤的同时保留髂内血流的潜力。

方法

对 46 例接受腔内治疗的 IIAA 患者进行回顾性分析。数据来自单中心腹主动脉瘤数据库。记录以下终点:动脉瘤排除的技术、技术成功率、围手术期发病率和死亡率、一期通畅率和中期随访。

结果

2009 年 9 月至 2016 年 5 月,共发现 46 例 55 个 IIAA 患者。大多数患者(n=39 [84.8%])有腹主动脉瘤,7 例为孤立性 IIAA(15.2%)。采用以下手术技术:髂内分支装置(IBD)植入术(n=29),髂内动脉(IIA)闭塞,或在闭塞前进行血管内线圈栓塞(n=23),或其他腔内技术(n=3)。IBD 植入的主要辅助技术成功率为 93.1%,通过覆盖动脉开口和其他技术闭塞 IIA 的成功率为 100%。总体 30 天死亡率为 4.3%(n=2),择期治疗患者为 0%。IBD 植入后的辅助中期通畅率为 93.1%。7 例(15.2%)患者因 IIA 或臀上动脉的故意或意外闭塞而出现臀肌跛行。IBD 植入后的中期随访再干预率为 13.8%(n=4),覆盖 IIA 开口后的再干预率为 4.3%(n=1)。在随访期间未观察到破裂,且在再干预期间未发生并发症。

结论

IBD 装置治疗腹主动脉瘤的技术效果良好,一期通畅率高,围手术期并发症发生率低。虽然成功排除动脉瘤并保留盆腔血流与中期随访期间更高的再干预率相关,但应考虑到这一点,尤其是在复杂的腹主动脉瘤腔内修复中。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验